Vitamin D3 for Life

Live Enlightened

Article

Vitamin D, Inflammation and Anaemia-Related Iron Restriction: Study Summary

Previous related pageVitamin D, Inflammation and Anaemia-Related Iron Restriction: Full StudyNext related pageWhy Similar Vitamin D Levels Can Produce Different Biological Responses: Full Study
Study at a glance

How are vitamin D, inflammation and iron availability linked?

This page summarises studies of vitamin D and iron availability in inflammatory bowel disease. Inflammation can raise hepcidin, a substance that reduces the release of iron from cells. Iron can therefore be present in the body but less available for making red blood cells. Ferritin, a measure linked to iron stores, can also rise during inflammation and needs to be interpreted in that context.

What did studies in children with inflammatory bowel disease find?

Lower vitamin D was associated with higher hepcidin and lower haemoglobin, the oxygen-carrying substance in red blood cells. This remained after researchers accounted for measured inflammation and other differences. The study observed relationships; it could not prove that low vitamin D caused the iron restriction.

What changed during treatment for bowel disease?

In a study following children through treatment, blood vitamin D rose by about 40% over two weeks. Hepcidin and C-reactive protein, a measured sign of inflammation, each fell by about 81%. Ferritin also fell. The children were receiving treatment for active bowel disease at the same time, so vitamin D cannot be credited with all these changes. Adult studies also found links between vitamin D measures and iron availability.

Can vitamin D replace treatment for the causes of anaemia?

Anaemia during inflammatory disease can have several causes, including blood loss, low iron stores and reduced iron release from cells. Nutritional and other disease-related factors also matter. Vitamin D may influence parts of this process without controlling it completely. These findings do not show that vitamin D supplements can replace investigation or treatment of iron deficiency, blood loss or inflammatory disease.

Read the full article below ↓

Inflammation can restrict iron availability by increasing hepcidin, reducing ferroportin-mediated iron release and retaining iron within storage and recycling cells. Human inflammatory-bowel-disease studies show that vitamin D status can track with this physiology: lower vitamin D status has been associated with higher hepcidin and lower haemoglobin, while prospective treatment data show large reductions in hepcidin as vitamin D status and inflammatory activity improve. This creates an important connection among Vitamin D and Iron Metabolism, inflammation and anaemia. For the detailed evidence review, see Vitamin D, Inflammation and Anaemia-Related Iron Restriction: Full Study.

Inflammation changes what iron markers mean

Hepcidin rises during inflammatory signalling and reduces cellular iron export. Ferritin can also rise as an acute-phase reactant, so apparently adequate ferritin does not necessarily mean that iron is readily available for erythropoiesis.

This pathway overlaps with Vitamin D and Chronic Inflammation, but vitamin D is only one regulator within the inflammatory environment.

IBD studies show an association with hepcidin and haemoglobin

In children with inflammatory bowel disease, vitamin D insufficiency was associated with higher hepcidin and lower haemoglobin after adjustment for measured inflammation and other clinical variables. The design was observational, so it cannot prove that low vitamin D caused the iron restriction.

A prospective paediatric study found that after two weeks of treatment, 25(OH)D rose by about 40% while hepcidin and C-reactive protein each fell by approximately 81%. Ferritin also fell. Because active IBD was being treated at the same time, the changes cannot be assigned entirely to vitamin D.

Vitamin D may interact with more than one iron pathway

Later adult IBD work associated vitamin D sufficiency with higher transferrin saturation and linked higher 1,25(OH)₂D:25(OH)D ratios with lower hepcidin. Experimental work also suggested regulation of intestinal ceruloplasmin.

The different roles of circulating 25(OH)D and active 1,25(OH)₂D make Vitamin D Testing: 25-OH-D vs 1,25-OH₂-D relevant to interpreting these findings.

The evidence does not make vitamin D an anaemia treatment

Anaemia in inflammatory disease can result from blood loss, true iron deficiency, hepcidin-mediated restriction, reduced erythropoietin responsiveness and other nutritional or disease-related factors. Vitamin D can intersect with this network without controlling it completely.

The strongest conclusion is that vitamin D status can participate in inflammatory iron physiology. It is not evidence that vitamin D supplementation replaces investigation or treatment of iron deficiency, blood loss or inflammatory disease.

Scientific sources

Vitamin D Status Is Associated with Hepcidin and Hemoglobin Concentrations in Children with Inflammatory Bowel Disease. PMID: 28700535.

Vitamin D Decreases Hepcidin and Inflammatory Markers in Newly Diagnosed Inflammatory Bowel Disease Paediatric Patients: A Prospective Study. PMID: 30840757.

Iron Deficiency in Inflammatory Bowel Disease Is Associated With Low Levels of Vitamin D Modulating Serum Hepcidin and Intestinal Ceruloplasmin Expression. PMID: 35029158.

Related reading

Physiology

Vitamin D and Chronic Inflammation

Explains how vitamin D relates to chronic inflammation, including cytokine balance, immune regulation, metabolic links, and long-term inflammatory signalling, without making treatment claims.

Read more →

Original sources

Source

Iron Deficiency in Inflammatory Bowel Disease Is Associated With Low Levels of Vitamin D Modulating Serum Hepcidin and Intestinal Ceruloplasmin Expression

Iron Deficiency in Inflammatory Bowel Disease Is Associated With Low Levels of Vitamin D Modulating Serum Hepcidin and Intestinal Ceruloplasmin Expression.

Publication details

Iron Deficiency in Inflammatory Bowel Disease Is Associated With Low Levels of Vitamin D Modulating Serum Hepcidin and Intestinal Ceruloplasmin Expression. PMID: 35029158.

Read more →